236 related articles for article (PubMed ID: 8010734)
1. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
Patel PS; Adhvaryu SG; Balar DB; Parikh BJ; Shah PM
Anticancer Res; 1994; 14(2B):747-51. PubMed ID: 8010734
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
[TBL] [Abstract][Full Text] [Related]
3. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
Ghosh M; Nayak BR
Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
[TBL] [Abstract][Full Text] [Related]
4. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
Patel PS; Rawal GN; Balar DB
Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers in leukemia: evaluation of serum levels of different forms of sialic acid, Regan isoenzyme and lactate dehydrogenase.
Patel PS; Adhvaryu SG; Baxi BR
Int J Biol Markers; 1991; 6(3):177-82. PubMed ID: 1791311
[TBL] [Abstract][Full Text] [Related]
6. Implications of detection of minimal residual disease.
Wörmann B
Curr Opin Oncol; 1993 Jan; 5(1):3-12. PubMed ID: 8427891
[TBL] [Abstract][Full Text] [Related]
7. Serum lactate dehydrogenase and its isoenzymes in leukemia patients: possible role in diagnosis and treatment monitoring.
Patel PS; Adhvaryu SG; Balar DB
Neoplasma; 1994; 41(1):55-9. PubMed ID: 8202197
[TBL] [Abstract][Full Text] [Related]
8. A case control study of glycoprotein status in ovarian carcinoma.
Aranganathan S; Senthil K; Nalini N
Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
[TBL] [Abstract][Full Text] [Related]
9. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
10. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
11. Chronic depression of serum concentrations of sialic acid in alloxan-induced diabetic rats.
Woods RJ; Sobocinski PZ; Canterbury WJ; Mathewson NS; Hartley KM
Am J Vet Res; 1975 Mar; 36(3):297-9. PubMed ID: 1115428
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
Bathi RJ; Nandimath K; Kannan N; Shetty P
Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
[TBL] [Abstract][Full Text] [Related]
13. Serum glycoconjugates in patients with anemia and myeloid leukemia.
Patel PS; Adhvaryu SG; Balar DB
Tumori; 1988 Dec; 74(6):639-44. PubMed ID: 3232207
[TBL] [Abstract][Full Text] [Related]
14. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
15. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
16. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
[TBL] [Abstract][Full Text] [Related]
17. [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia].
Aulbert E; Fromm H; Hornemann H
Med Klin (Munich); 1991 Jun; 86(6):297-304. PubMed ID: 1886510
[TBL] [Abstract][Full Text] [Related]
18. Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
Le Coutre P; Kreuzer KA; Na IK; Schwarz M; Lupberger J; Holdhoff M; Baskaynak G; Gschaidmeier H; Platzbecker U; Ehninger G; Prejzner W; Huhn D; Schmidt CA
Am J Hematol; 2003 Aug; 73(4):249-55. PubMed ID: 12879428
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation in leukaemia.
Ghalaut VS; Ghalaut PS; Singh S
J Assoc Physicians India; 1999 Apr; 47(4):403-5. PubMed ID: 10778525
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of water soluble and lipid soluble sialic acid levels as tumor markers.
Shamberger RJ
Anticancer Res; 1986; 6(4):717-20. PubMed ID: 3752951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
